🔗 Visit the ClinicalTrials.gov page for NCT01331135
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK. | Clin Cancer Res | 2013 | 1.02 |
| 2 | A review of targeted therapies evaluated by the pediatric preclinical testing program for osteosarcoma. | Front Oncol | 2013 | 0.95 |
| 3 | The rationale for targeted therapies in medulloblastoma. | Neuro Oncol | 2013 | 0.92 |
| 4 | Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy. | Paediatr Drugs | 2015 | 0.86 |
| 5 | Targeted therapies for advanced Ewing sarcoma family of tumors. | Cancer Treat Rev | 2015 | 0.81 |
| 6 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |